• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疟原虫清除率对马里儿童疟疾青蒿琥酯的反应:获得性免疫的影响。

Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.

机构信息

Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

J Infect Dis. 2013 Jun 1;207(11):1655-63. doi: 10.1093/infdis/jit082. Epub 2013 Feb 28.

DOI:10.1093/infdis/jit082
PMID:23448727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3636783/
Abstract

BACKGROUND

Artemisinin resistance, a long parasite clearance half-life in response to artemisinin, has been described in patients with Plasmodium falciparum malaria in southeast Asia. Few baseline half-lives have been reported from Africa, where artemisinins were recently introduced.

METHODS

We treated P. falciparum malaria in 215 Malian children aged 0.5-15 years with artesunate (0, 24, 48 hours) and amodiaquine (72, 96, 120 hours). We estimated half-life by measuring parasite density every 6 hours until undetectable and evaluated the effects of age, sex, ethnicity, and red blood cell (RBC) polymorphisms on half-life. We quantified the proportion of parasitized RBCs recognized by autologous immunoglobulin G (IgG).

RESULTS

The geometric mean half-life was 1.9 hours (95% confidence interval, 1.8-2.0) and did not correlate with parasite ex vivo susceptibility to artemisinins. In a linear model accounting for host factors, half-life decreased by 4.1 minutes for every 1-year increase in age. The proportion of parasitized RBCs recognized by IgG correlated inversely with half-life (r = -0.475; P = .0006).

CONCLUSIONS

Parasite clearance in response to artesunate is faster in Mali than in southeast Asia. IgG responses to parasitized RBCs shorten half-life and may influence this parameter in areas where age is not an adequate surrogate of immunity and correlates of parasite-clearing immunity have not been identified.

CLINICAL TRIALS REGISTRATION

NCT00669084.

摘要

背景

青蒿素耐药性是指疟原虫对青蒿素的清除半衰期延长,已在东南亚的恶性疟患者中有所描述。在青蒿素最近引入的非洲,报道的基线半衰期较少。

方法

我们用青蒿琥酯(0、24、48 小时)和阿莫地喹(72、96、120 小时)治疗了 215 名 0.5-15 岁的马里儿童恶性疟。我们通过每 6 小时测量一次寄生虫密度直到无法检测到的方法来估计半衰期,并评估年龄、性别、种族和红细胞(RBC)多态性对半衰期的影响。我们量化了被自身免疫球蛋白 G(IgG)识别的寄生 RBC 的比例。

结果

几何平均半衰期为 1.9 小时(95%置信区间,1.8-2.0),与寄生虫对青蒿素的体外敏感性无关。在一个考虑宿主因素的线性模型中,年龄每增加 1 岁,半衰期就会减少 4.1 分钟。被 IgG 识别的寄生 RBC 的比例与半衰期呈负相关(r = -0.475;P =.0006)。

结论

与东南亚相比,青蒿琥酯在马里的寄生虫清除速度更快。对寄生 RBC 的 IgG 反应缩短了半衰期,并且在年龄不是免疫的充分替代物的地区,以及尚未确定清除寄生虫免疫的相关因素的地区,可能会影响这一参数。

临床试验注册

NCT00669084。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b8/3636783/f652aa5ebf64/jit08204.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b8/3636783/15d652918429/jit08201.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b8/3636783/897b5d077921/jit08202.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b8/3636783/2fd57618f652/jit08203.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b8/3636783/f652aa5ebf64/jit08204.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b8/3636783/15d652918429/jit08201.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b8/3636783/897b5d077921/jit08202.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b8/3636783/2fd57618f652/jit08203.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b8/3636783/f652aa5ebf64/jit08204.jpg

相似文献

1
Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.疟原虫清除率对马里儿童疟疾青蒿琥酯的反应:获得性免疫的影响。
J Infect Dis. 2013 Jun 1;207(11):1655-63. doi: 10.1093/infdis/jit082. Epub 2013 Feb 28.
2
Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.在用青蒿琥酯治疗疟疾的马里免疫儿童中,恶性疟原虫清除迅速且与凹痕无关。
J Infect Dis. 2015 Jan 15;211(2):290-7. doi: 10.1093/infdis/jiu427. Epub 2014 Sep 2.
3
Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.青蒿琥酯高剂量或分剂量给药对耐青蒿素恶性疟原虫疟疾寄生虫清除的影响。
Clin Infect Dis. 2013 Mar;56(5):e48-58. doi: 10.1093/cid/cis958. Epub 2012 Nov 21.
4
Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives.优化采样设计以估计青蒿素衍生物治疗的疟原虫清除率。
Malar J. 2013 Nov 13;12:411. doi: 10.1186/1475-2875-12-411.
5
Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.抗疟功能免疫对青蒿素衍生物治疗疗效研究中寄生虫清除衡量标准的贡献。
J Infect Dis. 2019 Aug 30;220(7):1178-1187. doi: 10.1093/infdis/jiz247.
6
Host immunity to and the assessment of emerging artemisinin resistance in a multinational cohort.多国队列研究中的宿主免疫与青蒿素耐药性的评估。
Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3515-3520. doi: 10.1073/pnas.1615875114. Epub 2017 Mar 13.
7
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.青蒿素衍生物治疗恶性疟患者寄生虫清除的基线数据:一项个体患者数据荟萃分析。
Malar J. 2015 Sep 22;14:359. doi: 10.1186/s12936-015-0874-1.
8
Spread of artemisinin resistance in Plasmodium falciparum malaria.疟原虫青蒿素耐药性的传播。
N Engl J Med. 2014 Jul 31;371(5):411-23. doi: 10.1056/NEJMoa1314981.
9
Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.缅甸南部恶性疟原虫对青蒿琥酯的敏感性降低。
PLoS One. 2013;8(3):e57689. doi: 10.1371/journal.pone.0057689. Epub 2013 Mar 8.
10
Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009.1999 - 2009年在撒哈拉以南非洲地区进行的青蒿琥酯 - 阿莫地喹及对照治疗临床研究中恶性疟原虫的清除情况。
Malar J. 2014 Mar 25;13:114. doi: 10.1186/1475-2875-13-114.

引用本文的文献

1
Persistence of Residual Submicroscopic P. falciparum Parasitemia following Treatment of Artemether-Lumefantrine in Ethio-Sudan Border, Western Ethiopia.在埃塞俄比亚西部与苏丹接壤的边境地区,使用青蒿琥酯-咯萘啶治疗后,仍有残余的亚微观疟原虫寄生。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0000222. doi: 10.1128/aac.00002-22. Epub 2022 Aug 22.
2
Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia.比较刚果民主共和国和亚洲地区青蒿素疗效研究中的抗体反应和寄生虫清除率。
J Infect Dis. 2022 Aug 24;226(2):324-331. doi: 10.1093/infdis/jiac232.
3

本文引用的文献

1
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.柬埔寨西部磅士卑省的青蒿素耐药疟原虫:寄生虫清除率研究。
Lancet Infect Dis. 2012 Nov;12(11):851-8. doi: 10.1016/S1473-3099(12)70181-0. Epub 2012 Aug 30.
2
Artemisinin-resistant malaria: research challenges, opportunities, and public health implications.抗青蒿素疟疾:研究挑战、机遇和公共卫生影响。
Am J Trop Med Hyg. 2012 Aug;87(2):231-241. doi: 10.4269/ajtmh.2012.12-0025.
3
No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.
Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa.
加快撒哈拉以南非洲地区抗疟药物耐药性的分子监测。
Malar J. 2021 Oct 13;20(1):401. doi: 10.1186/s12936-021-03942-5.
4
Discrete Survival Model Analysis of Response to Artemisinin-Based Combination Therapies among Children in Regions of Varying Malaria Transmission in Cameroon.喀麦隆不同疟疾传播地区儿童对青蒿素联合疗法反应的离散生存模型分析
Pathogens. 2021 Aug 30;10(9):1106. doi: 10.3390/pathogens10091106.
5
Heme oxygenase-1 in protozoan infections: A tale of resistance and disease tolerance.血红素加氧酶-1 在原生动物感染中的作用:抵抗和疾病耐受的故事。
PLoS Pathog. 2020 Jul 21;16(7):e1008599. doi: 10.1371/journal.ppat.1008599. eCollection 2020 Jul.
6
High-efficiency enrichment enables identification of aptamers to circulating Plasmodium falciparum-infected erythrocytes.高效富集可鉴定针对循环疟原虫感染红细胞的适配体。
Sci Rep. 2020 Jun 16;10(1):9706. doi: 10.1038/s41598-020-66537-1.
7
Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy.青蒿琥酯单药疗法治疗后,两个马里村庄间疟原虫清除时间的差异。
Int J Infect Dis. 2020 Jun;95:399-405. doi: 10.1016/j.ijid.2020.03.082. Epub 2020 Apr 19.
8
Evaluation of residual submicroscopic Plasmodium falciparum parasites 3 days after initiation of treatment with artemisinin-based combination therapy.在开始使用基于青蒿素的联合疗法治疗 3 天后评估残留的亚微观疟原虫。
Malar J. 2020 Apr 21;19(1):162. doi: 10.1186/s12936-020-03235-3.
9
Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.恶性疟原虫Kelch13 蛋白突变在缅甸东北部地区恶性疟原虫种群中对青蒿素耐药性的介导作用。
mBio. 2020 Feb 25;11(1):e01134-19. doi: 10.1128/mBio.01134-19.
10
The extended recovery ring-stage survival assay provides a superior association with patient clearance half-life and increases throughput.扩展恢复环阶段存活测定法与患者清除半衰期具有更好的相关性,并提高了通量。
Malar J. 2020 Jan 31;19(1):54. doi: 10.1186/s12936-020-3139-6.
在马里,口服青蒿琥酯治疗无并发症恶性疟原虫感染后,没有寄生虫清除延迟的证据。
Am J Trop Med Hyg. 2012 Jul;87(1):23-8. doi: 10.4269/ajtmh.2012.12-0058.
4
A major genome region underlying artemisinin resistance in malaria.一个主要的基因组区域是导致疟疾对青蒿素产生抗药性的原因。
Science. 2012 Apr 6;336(6077):79-82. doi: 10.1126/science.1215966.
5
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.泰国西部边境地区青蒿素耐药疟疾的出现:一项纵向研究。
Lancet. 2012 May 26;379(9830):1960-6. doi: 10.1016/S0140-6736(12)60484-X. Epub 2012 Apr 5.
6
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.非洲劣质基本抗疟药物——亟待关注的公共卫生疏忽领域
Malar J. 2011 Dec 13;10:352. doi: 10.1186/1475-2875-10-352.
7
Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator.标准化恶性疟原虫清除率的测量:寄生虫清除估算器。
Malar J. 2011 Nov 10;10:339. doi: 10.1186/1475-2875-10-339.
8
Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations.疟原虫种群中对磺胺多辛耐药 dhps 等位基因的有限地域起源和全球传播。
J Infect Dis. 2011 Dec 15;204(12):1980-8. doi: 10.1093/infdis/jir664. Epub 2011 Oct 21.
9
The parasite clearance curve.寄生虫清除曲线。
Malar J. 2011 Sep 22;10:278. doi: 10.1186/1475-2875-10-278.
10
Microvascular sequestration of Plasmodium falciparum.恶性疟原虫的微血管隔离
Blood. 2011 Jun 16;117(24):6410. doi: 10.1182/blood-2010-09-305102.